Capital World Investors Portfolio holdings
Capital World Investors (CWI), a division of Capital Group, one of the oldest and largest investment management firms in the world, was established in 1931 and is headquartered in Los Angeles, California. Specializing in active investment management, CWI focuses on long-term growth through a research-intensive approach, managing hundreds of billions in assets primarily through equity-focused mutual funds and institutional portfolios. It serves a diverse client base, including individual investors, financial advisors, and institutions, and is known for its flagship funds like the American Funds, which emphasize fundamental analysis and a multiple-portfolio-manager system to mitigate risk. With a global reach and a reputation for disciplined, value-oriented investing, CWI remains a cornerstone of Capital Group’s mission to deliver consistent, superior returns.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$1.91B |
| 2 |
Johnson & Johnson
JNJ
|
+$1.8B |
| 3 |
Philip Morris
PM
|
+$1.28B |
| 4 |
Pfizer
PFE
|
+$1.18B |
| 5 |
Dollar General
DG
|
+$933M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$6.54B |
| 2 |
Merck
MRK
|
+$1.81B |
| 3 |
Charter Communications
CHTR
|
+$1.49B |
| 4 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$1.32B |
| 5 |
Home Depot
HD
|
+$1.3B |
Sector Composition
| 1 | Technology | 19.98% |
| 2 | Healthcare | 18.26% |
| 3 | Financials | 15.73% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Diamondback Energy
FANG
$38.9B
| $37.5M | 0.01% |
1,430,836
-3,907,926
| -73% | -$102M |
|
352
Abbott
ABT
$229B
| $35.7M | 0.01% |
452,156
+218,887
| +94% | +$17.3M |
|
353
Glaukos
GKOS
$4.62B
| $35.5M | 0.01% |
1,150,322
| – | – |
|
|
CCMP
354
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $35.1M | 0.01% |
307,100
+81,900
| +36% | +$9.35M |
|
355
Editas Medicine
EDIT
$240M
| $34.9M | 0.01% |
1,760,000
| – | – |
|
|
UN
356
DELISTED
Unilever NV New York Registry Shares
UN
| $34.1M | 0.01% |
698,374
+411,747
| +144% | +$20.1M |
|
357
Quince Therapeutics
QNCX
$85.9M
| $33.9M | 0.01% |
743,400
+171,073
| +30% | +$7.8M |
|
|
SGEN
358
DELISTED
Seagen Inc. Common Stock
SGEN
| $33.7M | 0.01% |
+292,402
| New | +$33.7M |
|
|
RVNC
359
DELISTED
Revance Therapeutics, Inc.
RVNC
| $31.5M | 0.01% |
2,130,000
| – | – |
|
360
Bank of N.T. Butterfield & Son
NTB
$1.89B
| $31.5M | 0.01% |
1,850,000
+287,042
| +18% | +$4.89M |
|
361
Amphenol
APH
$146B
| $31.5M | 0.01% |
1,729,000
-776,800
| -31% | -$14.2M |
|
362
BlackLine
BL
$3.36B
| $31.3M | 0.01% |
595,000
| – | – |
|
363
Cannae Holdings
CNNE
$1.12B
| $30.1M | 0.01% |
900,136
| – | – |
|
364
Helmerich & Payne
HP
$2.08B
| $29.7M | 0.01% |
1,900,000
-3,960,000
| -68% | -$62M |
|
365
Starbucks
SBUX
$94B
| $29.4M | 0.01% |
447,852
+19,063
| +4% | +$1.25M |
|
366
CoStar Group
CSGP
$37.7B
| $29.4M | 0.01% |
500,000
| – | – |
|
367
Fresh Del Monte Produce
FDP
$1.7B
| $28.4M | 0.01% |
1,028,000
| – | – |
|
368
Haemonetics
HAE
$2.47B
| $28.1M | 0.01% |
+282,322
| New | +$28.1M |
|
369
Novartis
NVS
$239B
| $27.8M | 0.01% |
336,883
+137,138
| +69% | +$11.3M |
|
|
CSFL
370
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $27M | 0.01% |
1,568,697
| – | – |
|
|
ACIA
371
DELISTED
Acacia Communications, Inc. Common Stock
ACIA
| $25.5M | 0.01% |
380,000
| – | – |
|
372
Live Nation Entertainment
LYV
$40B
| $25.4M | 0.01% |
+557,692
| New | +$25.4M |
|
|
WMGI
373
DELISTED
Wright Medical Group Inc
WMGI
| $25.2M | 0.01% |
879,857
| – | – |
|
374
Corpay
CPAY
$21.5B
| $25.1M | 0.01% |
134,483
-1,455,893
| -92% | -$272M |
|
375
Cavco Industries
CVCO
$4.32B
| $24.8M | 0.01% |
170,870
| – | – |
|